Literature DB >> 29172025

Vitamin D ratio and glycaemic control in individuals with type 2 diabetes mellitus: A systematic review.

Ramara Kadija Fonseca Santos1, Paula Nascimento Brandão-Lima2, Raissa Maria Dumas Delatore Tete3, Analícia Rocha Santos Freire3, Liliane Viana Pires3.   

Abstract

Several studies have suggested a favorable role for vitamin D in glycaemic metabolism and its potential as adjuvant treatment of type 2 diabetes mellitus. This review discusses the role of vitamin D in the glycaemic control of individuals with type 2 diabetes mellitus and evaluates the effect of vitamin D supplementation on glycaemic markers in this population. Literature searches were performed in the BIREME, LILACS, and PubMed databases using the Medical Subject Headings and words related to vitamin D, type 2 diabetes mellitus, and glycaemic control. Interventional and observational studies were considered eligible. The evaluation of the included studies was independently performed by 2 evaluators at all stages of selection, data extraction, and bias risk assessment. The primary outcome was the relationship between vitamin D levels and glucose metabolism markers in type 2 diabetes mellitus individuals. The secondary outcome was the effect of vitamin D supplementation on the glycaemic control markers in individuals with type 2 diabetes mellitus. The inverse relationship between vitamin D and variables of glucose metabolism was verified. Interventional studies revealed that vitamin D supplementation did not alter glycaemic control markers in most studies. Few studies have shown positive effects with a significant reduction in the percentage of glycated haemoglobin, insulin, and glucose concentrations, and changes in homeostatic model assessment-insulin resistance and beta cell, and quantitative insulin sensitivity check index. Therefore, despite the association of vitamin D with glucose metabolism, there is insufficient evidence of the beneficial effects of its supplementation on the metabolic control of type 2 diabetes mellitus.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cholecalciferol; hyperglycaemia; systematic review; vitamin D deficiency

Mesh:

Substances:

Year:  2017        PMID: 29172025     DOI: 10.1002/dmrr.2969

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  6 in total

1.  Association Between Vitamin D Levels and Glycemic Control Among Adult Diabetic Patients in Riyadh, Saudi Arabia.

Authors:  Saleh Abubaker; Abdulrahman Albasseet; Kossay A El-Abd; Asim A Alandijani; Yaser A Alendijani; Abdullah Alkhenizan
Journal:  Cureus       Date:  2022-06-13

2.  Lower serum 25-hydroxyvitamin D levels are associated with impaired glomerular filtration rate in type 2 diabetes patients.

Authors:  Angélica Dall'Agnol; Letícia de Almeida Brondani; Vítor da Agostim Cancelier; Eduardo Guimarães Camargo; Sandra Pinho Silveiro
Journal:  Ther Adv Endocrinol Metab       Date:  2020-07-27       Impact factor: 3.565

Review 3.  Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D.

Authors:  Alan Sacerdote; Paulomi Dave; Vladimir Lokshin; Gül Bahtiyar
Journal:  Curr Diab Rep       Date:  2019-09-10       Impact factor: 4.810

4.  Vitamin D and Periodontitis: A Systematic Review and Meta-Analysis.

Authors:  Vanessa Machado; Sofia Lobo; Luís Proença; José João Mendes; João Botelho
Journal:  Nutrients       Date:  2020-07-22       Impact factor: 5.717

5.  The association between the serum level of vitamin D and ischemic heart disease: a study from Jordan.

Authors:  Mohamad I Jarrah; Nizar M Mhaidat; Karem H Alzoubi; Nasr Alrabadi; Enas Alsatari; Yousef Khader; Moath F Bataineh
Journal:  Vasc Health Risk Manag       Date:  2018-06-12

6.  Vitamin D serum level in subjects with critical illness polyneuropathy and myopathy.

Authors:  Domenico Intiso; Andrea Fontana; Massimiliano Copetti; Luigi Amoruso; Michelangelo Bartolo; Andrea Santamato; Filomena Di Rienzo
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-03-03       Impact factor: 2.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.